Stock Region Penny Picks
Your daily dose of market movers, exciting updates, and a sprinkle of opinions to keep you informed and entertained!.
Stock Region Watchlist Newsletter - Thursday, August 28, 2025
The stocks featured in this report were previously delivered in our trading room in real-time. To access Stock Region’s real-time trade ideas, then be sure to purchase a membership now.
Disclaimer: This newsletter is for informational purposes only and should not be considered financial advice. Always do your own research and consult with a financial advisor before making investment decisions. Stocks mentioned here may carry significant risks, and past performance is not indicative of future results.
Market Movers & Breaking News
🚨 $BTAI - BioXcel Therapeutics
Big news for BioXcel! Their SERENITY At-Home Phase 3 trial hit its primary endpoint, paving the way for a supplemental New Drug Application (sNDA) for IGALMI®. This could mean a broader label and more opportunities for the company. Keep an eye on this one—it’s halted for news, but the potential here is exciting.
💉 $AZTR - Azitra, Inc.
Azitra has dosed its first patient in a Phase 1/2 trial for ATR-04, targeting oncology patients with EGFRi-associated rash. This is a niche but critical area in oncology care. Early-stage, but worth watching for updates.
📊 $FLNT - Fluent, Inc.
Fluent is making moves with a new partnership with Databricks and a key leadership hire. Expanding data intelligence capabilities is a smart play in today’s data-driven world. Could this be a turning point for Fluent?
🧬 $MBRX - Moleculin Biotech
Moleculin shared positive survival data for its AML treatment. At $0.5134, this stock is still in penny territory, but the data could spark interest. High risk, high reward? You decide.
⚠️ $PSNYW - Polestar Warrants
This one’s a wild ride—up 253% with no news. High-risk plays like this can be tempting, but tread carefully. Measure your risk/reward ratio before diving in.
🤖 $NAMI - Namibox
Namibox is launching the world’s first AI-powered learning glasses. This feels like a sci-fi movie come to life! If they can deliver on the promise, this could be a game-changer in the ed-tech space.
💰 $IMG - CIMG Inc.
CIMG is bolstering its digital asset reserves by selling $55 million in common stock for 500 Bitcoin. A bold move in the volatile crypto space—will it pay off?
🧪 $TELO - Telomir Pharmaceuticals
Telomir is making waves with its preclinical data on Telomir-1, a potential first-in-class epigenetic therapy. The science is fascinating, but it’s still early days. If you’re into biotech moonshots, this one’s for you.
🚗 $SPRC - SciSparc
SciSparc shareholders approved a merger with a leading parallel vehicle importer in Israel. Diversification or distraction? Time will tell.
🌱 $SMX - SMX
SMX is tackling plastics circularity, claiming to be the missing link in a broken system. With billions in demand, this could be a sustainability play to watch.
🌌 $ASTI - Ascent Solar Technologies
Ascent Solar signed an MOU to improve thin-film solar tech for space applications. Solar in space? Sounds like the future is now.
🧬 $IGC - IGC Pharma
IGC received a Notice of Allowance for a novel THC microdose treatment targeting stammering, stuttering, and Tourette’s Syndrome. A unique approach in a niche market—definitely one to monitor.
🎉 $THH - TryHard Holdings Limited
IPO alert! TryHard debuted at $7.86. This Japanese lifestyle entertainment company is all about immersive storytelling and cutting-edge tech. If you’re into experiential entertainment, this could be a fun one to follow.
🌿 $COOT & $MOVE
Both Australian Oilseeds ($COOT) and Movano Health ($MOVE) received Nasdaq listing extensions. A lifeline for these companies, but they’ll need to deliver results to stay afloat.
💡 $MRM - Medirom
Medirom’s REMONY device has been certified as a fatigue-driving prevention tool. A niche but important innovation in health tech.
This week’s watchlist is packed with biotech breakthroughs, sustainability plays, and even some crypto drama. Whether you’re a cautious investor or a thrill-seeker, there’s something here for everyone. Remember, the market is as unpredictable as ever, so stay informed and invest wisely.
Disclaimer: The information provided in this newsletter is not financial advice. Stock Region and its contributors are not responsible for any investment decisions made based on this content. Always consult a financial advisor and do your own research.